Preliminary results of a clinical study suggest that people who receive Johnson & Johnson’s single-dose COVID vaccine may have better protection from booster shots (booster) Pfizer or Moderna vaccines. A study by the US National Institutes of Health (NIH) found that those who received the Johnson & Johnson vaccine had …
Read More »EU Approves Pfizer Vaccine Booster for Ages 18 and Over
The European Union drug regulator Monday (4/10) gave support for booster injections or booster for Pfizer-BioNTech’s COVID-19 vaccine, for those aged 18 years and over. European Medicines Agency (EMA) said this booster dose “may be considered at least six months after the second dose, for persons aged 18 years and …
Read More »Pfizer Begins Clinical Trials of COVID-19 Preventive Drugs
Pharmaceutical company Pfizer said it had started large-scale clinical trials for a drug made to prevent people from contracting COVID-19. The trial for this oral antibiotic will involve 2,660 healthy adult participants living in a house with a person infected with COVID-19. Pfizer is also conducting studies of the drug …
Read More »CDC Approves Booster Injections for Some Pfizer Vaccine Recipients
The director of the US Centers for Disease Control and Prevention (CDC) has approved booster injections (booster) Pfizer’s COVID-19 vaccine for some people who had their first vaccination at least six months ago. Frontline workers – teachers, health care workers and others with jobs that put them at risk of …
Read More »Pfizer Ensures Vaccines Are Safe for Children 5-11 Years Old
Drugmakers Pfizer and BioNTech announced Monday (20/9) that their two-dose, low-dose COVID-19 vaccine is safe and effective for administration to children ages 5 to 11. The company from the United States (US) and its German partner, BioNTech, said that the results from trials showed the vaccine was well tolerated and …
Read More »FDA approves third dose of Pfizer COVID-19 vaccine for the elderly
The US Food and Drug Administration (FDA) on Wednesday (22/9) approved the Pfizer-BioNTech COVID-19 booster vaccine for those 65 years of age and older and some Americans who are at high risk. The move paves the way for accelerating the vaccination program. Booster dose or booster will be given at …
Read More »